California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

The number of new pharmaceutical companies being set up in Russia is steadily declining due to sanctions and the ever-growing ...

US biotech Avidity Biosciences’ stock rose 4% on Wednesday after the company announced that the US Food and Drug ...

Privately-held Danish dermatology specialist LEO Pharma today revealed that the US Food and Drug Administration (FDA) has ...

The US Food and Drug Administration (FDA) has extended the review period for the Biologics License Application (BLA) for ...

UK pharma major AstraZeneca is preparing to advance gefurulimab as a potential new treatment for generalized myasthenia ...

A new report has drawn attention to the growing number of prescription drugs being excluded from commercial insurance ...

Hospitals are rationing cancer treatments. Pharmacies are scrambling to fill routine antibiotic prescriptions. And across the USA, patients are facing growing delays, substitutions, or outright ...

Australian venture capital firm Brandon Capital has closed its largest fund to date, raising A$439 million ($296 million) for its sixth life sciences fund. The final close brings in new government ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved US pharma major AbbVie’s Elahere (mirvetuximab soravtansine) to treat adults with ovarian cancer, fallopian tube ...

China’s Alebund Pharmaceuticals announced positive top-line Phase III results highlighting that the use of AP301 demonstrated a statistically-significant and clinically-meaningful improvement in serum ...

Swiss pharma giant Roche has paused shipments of the gene therapy Elevidys (delandistrogene moxeparvovec) for new orders in certain countries outside the USA.